Sanchari Chatterjee

Dr. Sanchari Chatterjee

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2021 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
PMPrabhudutta Mamidi
Prabhudutta Mamidi
TNTapas Kumar Nayak
Tapas Kumar Nayak
Abhishek KumarAbhishek Kumar
Abhishek Kumar
SKSameer Kumar
Sameer Kumar
SCSanchari Chatterjee
Sanchari Chatterjee
SCSoma Chattopadhyay
Soma Chattopadhyay
Chikungunya virus (CHIKV) epidemics around the world have created public health concern with the unavailability of effective drugs and vaccines. This emphasizes the need for molecular understanding of host-virus interactions for developing effective targeted antivirals. Microarray analysis was carried out using CHIKV strain (Prototype and Indian) infected Vero cells and two host isozymes, MAPK activated protein kinase 2 (MK2) and MAPK activated protein kinase 3 (MK3) were selected for further analysis. The substrate spectrum of both enzymes is indistinguishable and covers proteins involved in cytokines production, endocytosis, reorganization of the cytoskeleton, cell migration, cell cycle control, chromatin remodeling and transcriptional regulation. Gene silencing and drug treatment were performed in vitro and in vivo to unravel the role of MK2/MK3 in CHIKV infection. Gene silencing of MK2 and MK3 abrogated around 58% CHIKV progeny release from the host cell and a MK2 activation inhibitor (CMPD1) treatment demonstrated 68% inhibition of viral infection suggesting a major role of MAPKAPKs during late CHIKV infection in vitro. Further, it was observed that the inhibition in viral infection is primarily due to the abrogation of lamellipodium formation through modulation of factors involved in the actin cytoskeleton remodeling pathway. Moreover, CHIKV-infected C57BL/6 mice demonstrated reduction in the viral copy number, lessened disease score and better survivability after CMPD1 treatment. In addition, reduction in expression of key pro-inflammatory mediators such as CXCL13, RAGE, FGF, MMP9 and increase in HGF (a CHIKV infection recovery marker) was observed indicating the effectiveness of the drug against CHIKV. Taken together it can be proposed that MK2 and MK3 are crucial host factors for CHIKV infection and can be considered as important target for developing effective anti-CHIKV strategies.

30 November 2023 in Journal of Virology
Verified
Journal Article
Open access
SCSanchari Chatterjee
Sanchari Chatterjee
SGSoumyajit Ghosh
Soumyajit Ghosh
ADAnkita Datey
Ankita Datey
CMChandan Mahish
Chandan Mahish
SCSoma Chattopadhyay
Soma Chattopadhyay
Viruses use various strategies to modulate host pathways and take benefit of host machineries for efficient infection. It has been reported that certain viruses manipulate the Wnt/β-catenin pathway; however, its role in Chikungunya virus (CHIKV) infection has not yet been investigated. Hence, the focus of the current study was to evaluate the importance of the Wnt/β-catenin pathway in CHIKV infection using in vitro , in vivo , and ex vivo models. The study revealed that CHIKV infection suppressed the active β-catenin protein associated with Wnt/β-catenin signaling, which, in turn, led to the reduction of cyclin-D1 and upregulation of glycogen synthase kinase-3β. Inhibition of β-catenin by an inhibitor (iCRT14) showed a drastic reduction in the viral RNA, protein, and new viral particle formation in vitro . Next, it was found that β-catenin is important in different phases of viral life cycle. Notably, the treatment of CHIKV-infected C57BL/6 mice with this drug reduced the disease score substantially with a 91.7% decrease in the viral load. Similar result was observed in human peripheral blood mononuclear cell-derived monocyte-macrophage populations and in physiologically relevant cells like RAW264.7 and C2C12 cells. Additionally, knockdown of β-catenin by siRNA drastically reduced viral particle formation. Further investigation revealed that CHIKV-nsP2 interacts with β-catenin during CHIKV infection. In conclusion, this work demonstrated for the first time the mechanistic insights regarding the role of the Wnt/β-catenin pathway for CHIKV infection that might contribute to the designing of effective therapeutics for the control of this virus infection in future. IMPORTANCE: Being obligate parasites, viruses use various host cell machineries in effectively replicating their genome, along with virus-encoded enzymes. In order to carry out infection and pathogenesis, viruses are known to manipulate fundamental cellular processes in cells and interfere with host gene expression. Several viruses interact with the cellular proteins involved in the Wnt/β-catenin pathway; however, reports regarding the involvement of protein components of the Wnt/β-catenin pathway in Chikungunya virus (CHIKV) infection are scarce. Additionally, there are currently no remedies or vaccines available for CHIKV. This is the first study to report that modulation of the Wnt/β-catenin pathway is crucial for effective CHIKV infection. These investigations deepen the understanding of the underlying mechanisms of CHIKV infection and offer new avenue for developing effective countermeasures to efficiently manage CHIKV infection.

11 August 2025 in Journal of General Virology
Verified
Journal Article
Open access
SVSuchanda Verma
Suchanda Verma
SCSanchari Chatterjee
Sanchari Chatterjee
SKSupriya Suman Keshry
Supriya Suman Keshry
ADAjit Kumar Dhal
Ajit Kumar Dhal
BBBijita Bhowmick
Bijita Bhowmick
AGArchana Ghatak
Archana Ghatak
Chikungunya is a febrile infection caused by the Chikungunya virus (CHIKV), an alphavirus which has emerged as a serious public health problem globally. Despite extensive research, our understanding of different host factors facilitating effective CHIKV infection is not clear yet. NEDD4, a member of the E3 ubiquitin ligase, is one such protein. Here, the importance of NEDD4 has been explored during CHIKV infection in vitro. It was observed that the level of NEDD4 is downregulated after CHIKV infection. Interestingly, the CHIKV-nsP3 level and the viral load were decreased significantly when NEDD4 was silenced, while a 93% decrease in the viral load was observed in the case of NEDD4 overexpression, indicating the importance of an optimum level of NEDD4 for effective CHIKV infection. Further study revealed that there was interaction between the NEDD4 and CHIKV-nsP3 proteins through co-immunoprecipitation (CO-IP) during CHIKV infection. Additionally, in silico data illustrated that the WW domain of NEDD4 can bind to the nsP3, as well as the macrodomain of nsP3 (nsp3-MD) of CHIKV. These data were further confirmed by the pull-down assay with purified nsP3-MD. The finding suggested that the host protein NEDD4 might interact directly with nsP3-MD during the CHIKV infection. However, the presence of a faint band of NEDD4 along with nsP3-MD in the pull-down assay may indicate the involvement of some other residues for this interaction. These in silico data were further confirmed by the CO-IP experiments, where all domains of nsP3, MD (macrodomain), AUD (alphavirus unique domain) and HVD (hypervariable domain) were found to interact with NEDD4. Additional experiments with a truncated form of MD, MD1 (1–100 residues of amino acid), revealed that this region is not able to maintain the interaction with NEDD4, indicating the crucial role of the C-terminal region of MD for this binding. In conclusion, these findings offer valuable insights about the importance of NEDD4 during CHIKV infection and the residues of nsP3 for its interaction, which might be useful to design future therapeutics against CHIKV.

12 December 2023 in Microbiology Spectrum
Verified
Journal Article
Open access
SCSanchari Chatterjee
Sanchari Chatterjee
BSBharat Bhusan Subudhi
Bharat Bhusan Subudhi
SCSoma Chattopadhyay
Soma Chattopadhyay

26 May 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
PMPrabhudutta Mamidi
Prabhudutta Mamidi
TNTapas Kumar Nayak
Tapas Kumar Nayak
Abhishek KumarAbhishek Kumar
Abhishek Kumar
SKSameer Kumar
Sameer Kumar
SCSanchari Chatterjee
Sanchari Chatterjee
SCSoma Chattopadhyay
Soma Chattopadhyay
Chikungunya virus (CHIKV) epidemics around the world have created public health concern with the unavailability of effective drugs and vaccines. This emphasizes the need for molecular understanding of host-virus interactions for developing effective targeted antivirals. Microarray analysis was carried out using CHIKV strain (Prototype and Indian) infected Vero cells and two host isozymes, MK2 and MK3 were selected for further analysis. Gene silencing and drug treatment were performed in vitro and in vivo to unravel the role of MK2/MK3 in CHIKV infection. Gene silencing of MK2 and MK3 abrogated around 58% CHIKV progeny release from the host cell and a MK2 activation (a) inhibitor (CMPD1) treatment demonstrated 68% inhibition of viral infection suggesting a major role of MAPKAPKs during the late phase of CHIKV infection in vitro . Further, it was observed that the inhibition in viral infection is primarily due to the abrogation of lamellipodium formation through modulation of factors involved in the actin cytoskeleton remodeling pathway that is responsible for releasing the virus from the infected cells. Moreover, CHIKV-infected C57BL/6 mice demonstrated reduction in the viral copy number, lessened disease score and better survivability after CMPD1 treatment. In addition, reduction in expression of key pro-inflammatory mediators such as CXCL13, RAGE, FGF, MMP9 and increase in HGF (a CHIKV infection recovery marker) was observed indicating the effectiveness of this drug against CHIKV. Additionally, CMPD1 also inhibited HSV1 and SARS CoV2-19 infection in vitro . Taken together it can be proposed that MK2 and MK3 are crucial host factors for CHIKV infection and can be considered as key targets for developing effective anti-CHIKV strategies in future. Author summary: Chikungunya virus has been a dreaded disease from the first time it occurred in 1952 Tanzania. Since then it has been affecting the different parts of the world at different time periods in large scale. It is typically transmitted to humans by bites of Aedes aegypti and Aedes albopictus mosquitoes. Although, studies have been undertaken to combat the disease still there are no effective strategies like vaccines or antivirals against it. Therefore it is essential to understand the virus and host interaction to overcome this hurdle. In this study two host factors MK2 and MK3 have been taken into consideration to see how they regulate the multiplication of the virus. The in vitro experiments demonstrated that inhibition of MK2 and MK3 restricted viral infection Further, it was observed that this is due to the blocking of lamellipodium formation by modifying the factors involved in the actin cytoskeleton remodeling pathway that is responsible for releasing the virus from the infected cells. Besides, decreased disease score as well as better survivability was noticed in the in vivo experiments with mice. Therefore, MK2 and MK3 could be considered as the key targets for controlling CHIKV infection.

1 June 2023
Verified
Preprint
Open access
PDF file
SSSoumya Sengupta
Soumya Sengupta
SKShubham Shaw K
Shubham Shaw K
SCSanchari Chatterjee
Sanchari Chatterjee
GBGargee Bhattacharya
Gargee Bhattacharya
PKPrakash Barik K
Prakash Barik K
SDSatish Devadas
Satish Devadas
SARS-CoV2 infection has caused an increase in mortality and morbidity but with vaccination, the disease severity has significantly reduced. But with emergence of various variants of concerns (VOCs), the vaccine breakthrough infection has also increased. Here, we studied circulating spike specific T follicular response (cTfh) in infection naïve vaccinees and convalescent vaccinees (individuals who got delta breakthrough infection after 2 doses of BBV152 vaccine) to understand their response as they are the most crucial cells that are involve in vaccine mediated protection by helping in B-cell maturation. Our results indicated that cTfh cells in both the groups recognized wild type and delta spike protein but memory response to wild type spike was superior in infection naïve than in convalescent group. The cytokine response particularly IL-21 from cTfh cells was also higher in infection naïve than convalescent vaccines indicating a dampened cTfh response in convalescent vaccines after breakthrough infection. Also, there was positive correlation between IL-21 from cTfh cells and neutralizing antibodies of infection naïve vaccinees. Multiple cytokine analysis also revealed higher inflammation in convalescent vaccinees. Our data indicated necessity of third booster dose may be individual specific depending in the steady state functional phenotype of immune cells.